MIRACLE Medical Technology Act of 2024
The MIRACLE Medical Technology Act of 2024 establishes a formal U.S.-Israel collaboration program to advance joint development and delivery of healthcare products and services. It creates a U.S.-Israel Health Care Collaboration Center to facilitate research (including medical devices, pharmaceuticals, and digital health), regulatory alignment, manufacturing partnerships, and disease prevention efforts. The program requires annual funding of $8 million (2025-2029) and focuses on concrete mechanisms like shared clinical trials, data-sharing frameworks, and joint manufacturing facilities. It directly affects U.S. and Israeli healthcare institutions, medical technology companies, and research organizations working on healthcare innovation.
Bill status
in committee
1 of 4 stages cleared
Introduction
May 2024
Committee Review
Floor Vote
President
Introduced May 8, 2024
Last action May 17, 2024
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
0
Committee
2
May 17, 2024
Committee
Referred to the Subcommittee on Health.
lower
May 8, 2024
Committee
Referred to the House Committee on Energy and Commerce.
lower
May 8, 2024
Introduced
Introduced in House
lower
1 primary · 2 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Vern Buchanan
RRepublican
Co
Darren Soto
DDemocratic
Co
Mariannette Miller-Meeks
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 8299
Scope: US
Hi! I can help you understand HR 8299. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline